(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|
Turnover | 48.07%895.28M | --219.45M | 15.37%604.65M | --524.11M |
Operating income | 48.07%895.28M | 219.45M | 15.37%604.65M | 524.11M |
Cost of sales | -28.99%-715.66M | ---184.76M | -20.01%-554.83M | ---462.32M |
Operating expenses | -28.99%-715.66M | -184.76M | -20.01%-554.83M | -462.32M |
Gross profit | 260.51%179.62M | 34.69M | -19.36%49.82M | 61.79M |
Selling expenses | -31.13%-134.83M | ---81.55M | -13.65%-102.83M | ---90.48M |
Administrative expenses | -39.96%-339.67M | ---224.06M | -11.21%-242.7M | ---218.23M |
Research and development expenses | -11.17%-220.88M | ---167.25M | 13.95%-198.69M | ---230.89M |
Revaluation surplus | 83.40%-3.12M | --95K | -10,894.15%-18.8M | ---171K |
-Changes in the fair value of derivative financial instruments | ---- | ---- | -3,142.34%-19.68M | ---607K |
-Changes in the fair value of financial assets | -454.14%-3.12M | --95K | 102.06%881K | --436K |
Impairment and provision | -313.77%-63.97M | ---21.59M | 89.31%-15.46M | ---144.64M |
-Other impairment is provision | -313.77%-63.97M | ---21.59M | 89.31%-15.46M | ---144.64M |
Operating interest expense | 2.23%-47.93M | ---36.14M | 2.08%-49.02M | ---50.06M |
Special items of operating profit | 2.29%54.87M | --36.08M | 75.36%53.64M | --30.59M |
Operating profit | -9.90%-575.91M | -459.73M | 18.39%-524.03M | -642.09M |
Share of profits of associates | -43.04%-3.86M | ---3.06M | -9.29%-2.7M | ---2.47M |
Share of profit from joint venture company | ---- | ---- | -226.09%-18.75M | ---5.75M |
Earning before tax | -6.29%-579.77M | -462.78M | 16.12%-545.47M | -650.3M |
Tax | 457.35%2.24M | --2.85M | 84.31%-626K | ---3.99M |
After-tax profit from continuing operations | -5.76%-577.53M | -459.93M | 16.54%-546.1M | -654.29M |
Earning after tax | -5.76%-577.53M | -459.93M | 16.54%-546.1M | -654.29M |
Minority profit | -19.75%-48.06M | ---35.8M | 50.75%-40.13M | ---81.49M |
Profit attributable to shareholders | -4.65%-529.47M | -424.13M | 11.67%-505.97M | -572.8M |
Basic earnings per share | 3.27%-6.51 | -5.22 | 23.61%-6.73 | -8.81 |
Diluted earnings per share | 3.27%-6.51 | -5.22 | 23.61%-6.73 | -8.81 |
Currency Unit | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data